Farms.com Home   News

AFBF Welcomes EPA Announcement on Renewable Volume Obligations

AFBF Welcomes EPA Announcement on Renewable Volume Obligations

American Farm Bureau Federation President Zippy Duvall commented today on the Environmental Protection Agency’s announcement regarding the Renewable Fuel Standard.

“Today’s EPA announcement is welcome news for farmers and ranchers as well as America’s families who are dealing with record-high fuel prices. AFBF appreciates that the Biden administration has upheld the promise to honor the critical role that renewable fuels play in supporting the rural economy.

“The use of homegrown renewable fuels provides an affordable option at the pump, while reducing greenhouse gas emissions the equivalent of taking 18 million cars off the road per year. With wholesale prices for ethanol currently lower than gasoline in many regions of the country, increased blending should lead to lower prices at the pump. Homegrown ethanol and biodiesel are especially important as we face global uncertainties. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.